Search results for PLK1 antibody

Anti-PLK1 Antibody (R3N01), AntibodySystem, RHE97403

Anti-PLK1 Antibody (R3N02), AntibodySystem, RHE97404

Anti-PLK1 antibody [AZ34], Abcam, AB12211

Anti-PLK1 antibody [AZ44], Abcam, AB12212

Anti-PLK1 antibody [EPR19534], Abcam, AB189139

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-PLK1 Antibody (R1Y72), AntibodySystem, RHE97402

Anti-Human PLK1 Antibody (3H10), AntibodySystem, RHE97401

PLK1 Antibody (YA4084)(PBS only), MedChemexpress, HY-P84387A

PLK1 Antibody (YA4084) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PLK1.

PE Anti-PLK1 antibody [EPR19534], Abcam, AB318352

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.

APC Anti-PLK1 antibody [EPR19534], Abcam, AB318455

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies . How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone.